Tilray Brands (TLRY) Competitors C$7.50 +0.17 (+2.32%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock TLRY vs. BHC, SLS, AUP, CARA, and CRONShould you buy Tilray Brands stock or one of its competitors? MarketBeat compares Tilray Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tilray Brands include Bausch Health Companies (BHC), Solaris Resources (SLS), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry. TLRY vs. BHCTLRY vs. SLSTLRY vs. AUPTLRY vs. CARATLRY vs. CRONHow does Tilray Brands compare to Bausch Health Companies?Tilray Brands (TSE:TLRY) and Bausch Health Companies (TSE:BHC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation. Which has more volatility and risk, TLRY or BHC? Tilray Brands has a beta of 3.243166, meaning that its stock price is 224% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.631102, meaning that its stock price is 37% less volatile than the broader market. Is TLRY or BHC more profitable? Bausch Health Companies has a net margin of -13.54% compared to Tilray Brands' net margin of -158.75%. Bausch Health Companies' return on equity of 120.43% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets Tilray Brands-158.75% -88.06% -1.41% Bausch Health Companies -13.54%120.43%4.16% Which has preferable earnings and valuation, TLRY or BHC? Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/ABausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A Do analysts rate TLRY or BHC? Tilray Brands currently has a consensus target price of C$13.30, suggesting a potential upside of 77.33%. Given Tilray Brands' higher probable upside, equities research analysts clearly believe Tilray Brands is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals have more ownership in TLRY or BHC? 4.1% of Tilray Brands shares are owned by institutional investors. Comparatively, 10.0% of Bausch Health Companies shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Comparatively, 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to TLRY or BHC? In the previous week, Bausch Health Companies had 12 more articles in the media than Tilray Brands. MarketBeat recorded 12 mentions for Bausch Health Companies and 0 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.25 indicating that Tilray Brands is being referred to more favorably in the media. Company Overall Sentiment Tilray Brands Neutral Bausch Health Companies Neutral SummaryBausch Health Companies beats Tilray Brands on 9 of the 14 factors compared between the two stocks.How does Tilray Brands compare to Solaris Resources?Tilray Brands (TSE:TLRY) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk. Is TLRY or SLS more profitable? Solaris Resources has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Solaris Resources' return on equity of 60.97% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets Tilray Brands-158.75% -88.06% -1.41% Solaris Resources N/A 60.97%-51.67% Which has better earnings & valuation, TLRY or SLS? Solaris Resources has lower revenue, but higher earnings than Tilray Brands. Solaris Resources is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/ASolaris ResourcesN/AN/A-C$46.49M-C$0.19N/A Which has more risk and volatility, TLRY or SLS? Tilray Brands has a beta of 3.243166, meaning that its share price is 224% more volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.884686, meaning that its share price is 88% more volatile than the broader market. Does the media prefer TLRY or SLS? In the previous week, Tilray Brands' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score. Company Overall Sentiment Tilray Brands Neutral Solaris Resources Neutral Do insiders and institutionals have more ownership in TLRY or SLS? 4.1% of Tilray Brands shares are owned by institutional investors. Comparatively, 16.0% of Solaris Resources shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Comparatively, 40.6% of Solaris Resources shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate TLRY or SLS? Tilray Brands presently has a consensus target price of C$13.30, suggesting a potential upside of 77.33%. Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 39.89%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Solaris Resources.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummarySolaris Resources beats Tilray Brands on 8 of the 13 factors compared between the two stocks.How does Tilray Brands compare to Aurinia Pharmaceuticals?Aurinia Pharmaceuticals (TSE:AUP) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Is AUP or TLRY more profitable? Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets Aurinia PharmaceuticalsN/A N/A N/A Tilray Brands -158.75%-88.06%-1.41% Do institutionals & insiders hold more shares of AUP or TLRY? 4.1% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor AUP or TLRY? In the previous week, Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score. Company Overall Sentiment Aurinia Pharmaceuticals Neutral Tilray Brands Neutral Which has stronger earnings and valuation, AUP or TLRY? Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/ATilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/A Do analysts recommend AUP or TLRY? Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 77.33%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTilray Brands beats Aurinia Pharmaceuticals on 7 of the 11 factors compared between the two stocks.How does Tilray Brands compare to Cara Operations?Cara Operations (TSE:CARA) and Tilray Brands (TSE:TLRY) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends. Which has better earnings and valuation, CARA or TLRY? Cara Operations has higher earnings, but lower revenue than Tilray Brands. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCara OperationsN/AN/AN/AN/AN/ATilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/A Do insiders and institutionals have more ownership in CARA or TLRY? 4.1% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is CARA or TLRY more profitable? Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets Cara OperationsN/A N/A N/A Tilray Brands -158.75%-88.06%-1.41% Does the media prefer CARA or TLRY? In the previous week, Cara Operations had 1 more articles in the media than Tilray Brands. MarketBeat recorded 1 mentions for Cara Operations and 0 mentions for Tilray Brands. Cara Operations' average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score. Company Overall Sentiment Cara Operations Neutral Tilray Brands Neutral Do analysts prefer CARA or TLRY? Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 77.33%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cara Operations.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTilray Brands beats Cara Operations on 5 of the 9 factors compared between the two stocks.How does Tilray Brands compare to Cronos Group?Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership. Which has more volatility and risk, CRON or TLRY? Cronos Group has a beta of 1.11805, meaning that its share price is 12% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.243166, meaning that its share price is 224% more volatile than the broader market. Do institutionals & insiders believe in CRON or TLRY? 4.4% of Cronos Group shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend CRON or TLRY? Cronos Group presently has a consensus target price of C$4.75, indicating a potential upside of 24.67%. Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 77.33%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CRON or TLRY more profitable? Cronos Group has a net margin of -1.29% compared to Tilray Brands' net margin of -158.75%. Cronos Group's return on equity of -0.19% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-1.29% -0.19% -3.73% Tilray Brands -158.75%-88.06%-1.41% Which has better earnings and valuation, CRON or TLRY? Cronos Group has higher earnings, but lower revenue than Tilray Brands. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$159.54M8.92-C$32.78MN/AN/ATilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/A Does the media prefer CRON or TLRY? In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score. Company Overall Sentiment Cronos Group Neutral Tilray Brands Neutral SummaryCronos Group beats Tilray Brands on 8 of the 13 factors compared between the two stocks. Get Tilray Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLRY vs. The Competition ExportMetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$897.03MC$2.22BC$6.45BC$12.16BDividend YieldN/A2.95%2.76%6.20%P/E Ratio-0.515.1617.9337.64Price / Sales1.051,770.59553.9211.68Price / Cash5.9510.1843.4982.29Price / Book0.5510.6110.374.50Net Income-C$183.24MC$20.70BC$3.57BC$299.09M7 Day Performance3.02%5.88%6.01%1.38%1 Month Performance-18.74%3.71%3.52%1.46%1 Year Performance25.00%23.05%34.13%55.45% Tilray Brands Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLRYTilray Brands1.2803 of 5 starsC$7.50+2.3%C$13.30+77.3%+22.2%C$897.03MC$858.28MN/A2,650BHCBausch Health Companies0.7284 of 5 starsC$7.56+3.1%N/A+23.4%C$2.82BC$10.53BN/A19,900SLSSolaris Resources1.5077 of 5 starsC$13.53+4.5%C$19.50+44.1%+113.8%C$2.26BN/AN/A10AUPAurinia PharmaceuticalsN/AN/AN/AN/AC$2.15BC$57.59MN/A300High Trading VolumeCARACara OperationsN/AN/AN/AN/AC$1.62BN/AN/A80 Related Companies and Tools Related Companies BHC Competitors SLS Competitors AUP Competitors CARA Competitors CRON Competitors ITH Competitors TEV Competitors NOT Competitors PYR Competitors NVO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:TLRY) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tilray Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tilray Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
